27 August 2026
Rasonque, a pancreatic cancer treatment from Revolution Medicines, offers a new option for advanced patients. Discover its benefits.
16 April 2026
Daraxonrasib pancreatic cancer trial results show that Revolution Medicines' new therapy is doubling survival rates and reshaping oncology.